Articles On Patrys (ASX:PAB)
Title | Source | Codes | Date |
---|---|---|---|
Closing Bell: ASX slips as Fed decision looms
ASX gives back gains ahead of Fed decision Vulcan and DigiCo rise MinRes completes $780m gas deal with Hancock Prospecting The ASX gave back its earlier gains this afternoon as investors adopted a more cautious approach ahead of the US... |
Stockhead | PAB | 6 days ago |
Health Check: It’s a wipe out! Percheron shares tumble up to 91pc on rare genetic disease trial failure
Percheron’s Duchenne muscular dystrophy trial has been a compete flop Canaccord Genuity says Opthea shares are worth at least double their current price Neurizon asks US regulator for motor neurone disease trial go-ahead Firstly, full... |
Stockhead | PAB | 1 week ago |
Crucible: Dr Boreham’s A-To-Z of 2024 biotech
From artificial intelligence (A.I) to zygotes, the biotech sector this year delivered the A to Z of excitement, intrigue, occasional disappointment and downright disaster. His virtual stethoscope on hand, Dr Boreham was on duty to diagnose... |
Stockhead | PAB | 1 week ago |
Closing Bell: ASX slides lower again; and long-awaited data centre REIT, DigiCo, slips on IPO debut
ASX drops to 4-week low, miners lead losses Rio Tinto slumps after $2.5bn lithium investment, iron ore prices fall DigiCo REIT slips on IPO debut The ASX has closed lower by 0.4% on Friday to near its lowest level in a month. For the we... |
Stockhead | PAB | 1 week ago |
ASX November Health Winners: Paradigm, Imricor lead sector as momentum returns
The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX Paradigm Biopharmaceuticals rose 151% in Novembe... |
Stockhead | PAB | 3 weeks ago |
ASX November Winners: The 50 best stocks as ASX 200 reached record high
The S&P/ASX 200 rose 4% in November to a new record high of 8436.23 points as volatility fell following US election Information Technology led the gainers rising 10% in November and remained top performer YTD, up 56.79% NoviqTech rose... |
Stockhead | PAB | 3 weeks ago |
Closing Bell: ASX slides from record high; expert says December pullback may encourage buying
ASX loses momentum after near-record high Tech stocks lead, but CSL falls; retail sales rise 0.6% in October Northern Star to buy De Grey for $5 billion The ASX has lost some of its early momentum today, pulling back from a record high... |
Stockhead | PAB | 3 weeks ago |
Closing Bell: ASX up on broad rally; but City Chic tumbles heavily after trading update
ASX rises on rally across the board Israel and Hezbollah agree to 60-day ceasefire City Chic tumbles after downbeat update The Aussie share market enjoyed a solid ride on Wednesday, driven by a broad rally as optimism from Wall Street’s... |
Stockhead | PAB | 4 weeks ago |
Health Check: Chinese consumer market is a thing of beauty, says EZZ Life Sciences
Chinese shoppers have not lost their appetite for EZZ’s health and beauty products Ho-Ho-Ho (Chi Minh)! Viet deal is an early Xmas prez for Truscreen holders Patrys says it will focus on its Plan B drug candidate China is a tough consum... |
Stockhead | PAB | 1 month ago |
New Therapeutic Strategies Emerging for Small Cell Lung Cancer
Highlights Enhanced understanding of SCLC subtypes drives tailored treatment approaches. Immunotherapy and antibody-drug conjugates emerge as key strategies. Asia-Pacific region identified as a critical area for further clinica... |
Kalkine Media | PAB | 1 month ago |
Closing Bell: ASX slips as China-exposed miners retreat; Bitcoin rockets above US$81k
ASX starts week lower with mining stocks under pressure Resolute mining plunges after CEO detained in Mali Bitcoin surges past US$81k as Trump’s win fuels optimism The ASX had a rough start to the week, with mining stocks dragging the m... |
Stockhead | PAB | 1 month ago |
Closing Bell: ASX pops on tech, banks, goldies and possible China ‘bazooka style’ stimulus
ASX rallies broadly as tech stocks lead Commonwealth Bank hits record, Neuren jumps Asian markets rise, China stimulus eyed The ASX was riding the coattails of a strong Wall Street session, with tech stocks leading the charge. At the c... |
Stockhead | PAB | 1 month ago |
October Health Winners: Uscom, Respiri lead sluggish sector, but ‘time in the market, not timing, is key’
ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th... |
Stockhead | PAB | 1 month ago |
ASX October Winners: The 50 best stocks in weaker month for markets
The S&P/ASX 200 fell 1.3% in October with small cap companies outperforming S&P Dow Jones Indices said financials led the gains in October and is up 30% YTD Ovanti rose 525% in October after appointment of former Zip US CFO Simon K... |
Stockhead | PAB | 1 month ago |
Closing Bell: Macquarie drags down bank stocks; Ironbark Zinc soars as Zelenski takes the chair
ASX opens November lower, led by financial sector sell-off Macquarie Group fell after profit decline Ironbark Zinc jumps 75% on new leadership The ASX kicked off November with a thud, sliding about 0.5%. This follows a tough session o... |
Stockhead | PAB | 1 month ago |
Closing Bell: ASX dips as AGL stalls; Talga skyrockets after Sweden approves graphite mine
ASX slips amid earnings updates and company meetings AGL drops over 6pc after downgrade, while Origin Energy rises Talga surges after Sweden approves graphite mine The ASX slipped by 0.22% after being dragged by a flurry of company... |
Stockhead | PAB | 1 month ago |
Closing Bell: ASX up as Myer-Premier deal excites market; ‘Trump trade’ Bitcoin above US$71k
ASX rises following Wall Street’s lead Cettire drops 12pc after disappointing earnings update Retail house Premier Investments surge after potential Myer deal The ASX rose by 0.34% on Tuesday following Wall Street’s lead. Consumer dis... |
Stockhead | PAB | 1 month ago |
Closing Bell: Arcadium holders cash in, Oil rallies as Milton hits, and GYG keeps momentum going
ASX gains as energy and mining stocks rally Arcadium Lithium surges after Rio acquisition, while GYG reports strong Q1 Hurricane Milton lands and pushes oil prices higher The ASX gained ground by 0.3% on Thursday and neared its recor... |
Stockhead | PAB | 2 months ago |
Closing Bell: Investors left high and dry after China disappoints; Iron ore, oil stocks swing to losses
ASX fell as mining stocks dropped on China’s lack of stimulus Brent oil dipped below US$80 Big lithium stocks fall, but smaller players keep gaining after Rio Tinto’s Arcadium takeover talks The ASX closed lower by 0.35% in a volatile... |
Stockhead | PAB | 2 months ago |
Closing Bell: Energy stocks cushion ASX’s mini crash; Infinity soars on Cangai copper acquisition
ASX 200 index falls despite gains in energy stocks Smaller oil and gas firms benefit from rising crude prices Iron ore stocks drop as prices retreat The ASX 200 index fell hard on Friday, down by 0.75%, despite some gains in the Ener... |
Stockhead | PAB | 2 months ago |
Closing Bell: Lithium stocks tumble after Pilbara selldown; Island Pharma surges 30pc
ASX edges down in a quiet market Pilbara Minerals falls 5pc as share block sale is reported Westpac sells auto finance unit for up to $1.6 billion The ASX has lifted slightly on Thursday, up by 0.1%, as traders remain cautious amid... |
Stockhead | PAB | 2 months ago |
Top 10 at 11: A dengue fever tackler and a junior copper hunter make the news grade this morning
Good morning, and welcome to Stockhead’s Top 10 at somewhere near 11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | PAB | 2 months ago |
Closing Bell: Oil stocks soar, goldies rally as traders seek safe haven amid rising conflict
ASX flattish amid rising Middle East tensions Crude oil prices surge 5pc, pushing oil stocks higher Gold miners gain as investors seek safe havens The ASX shifted from early gains to a mostly flat finish as investors turned to safer... |
Stockhead | PAB | 2 months ago |
Health Check: Farewell, adieu as Argent Biopharma holders back ASX delisting
Argent Biopharma packs its bags for London on a one-way ticket Patrys shares slump 50% on cancellation of key drug program Painchek targets US market for its pain detection app Health Check is renowned biotech journo Tim Boreham’s daily... |
Stockhead | PAB | 2 months ago |
Top 10 at 11: As global conflicts rage, an ASX defence data-security play rises
Good morning, and welcome to Stockhead’s Top 10 at somewhere near 11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | PAB | 2 months ago |
September
Health Winners: EZZ and Althea lead upbeat sector sparked by Fed rate cut
Healthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as Fed cuts rates How ASX biotechs performed in the month of September The S&P 500 Health Care Index, a key world benchmark for health... |
Stockhead | PAB | 2 months ago |
Closing Bell: Iron ore giants help ASX to another record; RBA rate cut far-off as job market stays tight
ASX200 hits record high driven by US Fed interest rate cut Mining stocks surge as iron ore prices rebound ALS shares drop 10pc, Monadelphous rises on new contracts The ASX200 hit yet another record high today, boosted by the first inte... |
Stockhead | PAB | 3 months ago |
August Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’
ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment The ASX Healthcare Index (AS... |
Stockhead | PAB | 3 months ago |
Closing Bell: Origin, Cochlear dive on earnings; RBA rate cut looks less likely after jobs report
ASX up as earnings season rolls on; Origin down 10pc, Telstra up 3pc Australia’s unemployment rate edged up to 4.2pc from 4.1pc Iron ore futures dropped below US$94 per ton The ASX edged slightly higher by 0.1% on Thursday, boosted by a... |
Stockhead | PAB | 4 months ago |
Closing Bell: ASX resets on mild mannered Monday gains
ASX rises circa 0.5pc Consumer stocks in focus this week SGQ and PHX lead small caps Aussie stocks have closed higher on Monday as IT and retail stocks added strength to sentiment. The S&P/ASX200 closed higher, gaining 36.00 points... |
Stockhead | PAB | 4 months ago |
Top 10 at 11: Tanks and family surveillance are in the news today
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | PAB | 4 months ago |
July Health Winners: Oncosil, Zelira lead as ASX biotechs power through another strong month
S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July The S&P/ASX 200 Health Care index [XHJ]... |
Stockhead | PAB | 4 months ago |
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month In a major blow for... |
Stockhead | PAB | 4 months ago |
Top 10 at 11-ish: A Big Red peggie gets even bigger and QLD gets a high-grade gold-copper hit
Good morning, and welcome to Stockhead’s Top 10 at shortly-after-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the t... |
Stockhead | PAB | 5 months ago |
ASX Health June Winners: Actinogen and Optiscan led a sector in good shape
The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase... |
Stockhead | PAB | 5 months ago |
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year
S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month The S&P/ASX 200 Health Care [XHJ] closed flattish for the month o... |
Stockhead | PAB | 6 months ago |
Check Up: Alzheimer’s is ‘preventable’, so here’s what you must do; and recent ASX biotech winners
Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month The phrase ‘you are what you eat’ was coined almost a c... |
Stockhead | PAB | 7 months ago |
Top 10 at 10: HIV budget boosts and a couple of promising copper, gold drill campaigns
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | PAB | 7 months ago |
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different
ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month The S&P/ASX 200 Health Care [XHJ] had a soft month in April... |
Stockhead | PAB | 7 months ago |
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners
There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month Scientists have made a significant b... |
Stockhead | PAB | 8 months ago |
Closing Bell: ASX gains as lithium, iron ore miners dazzle; copper and gold stocks extend rally
The ASX200 closed +0.5% higher on Tuesday on the back of a big lift in the Mining sector. Lithium stocks led, with IGO (ASX:IGO) and Pilbara (ASX:PLS) gaining around 3%. Iron ore miners rallied after the Nymex CFR China, 62% Fe price swu... |
Stockhead | PAB | 8 months ago |
Patrys releases positive data from deoxymabs study to treat ANCA vasculitis
Patrys (ASX: PAB) has released positive data from pre-clinical studies using deoxymabs PAT-DX1 and PAT-DX3 in animal models of the autoimmune disease anti-neutrophil cytoplasmic antibody (ANCA) vasculitis. The therapeutic antibody developme... |
smallcapsau.mystagingwebsite.com | PAB | 8 months ago |
ASX Health Stocks: Patrys and Next Science jump after presenting data on studies
Patrys’ deoxymabs data on vasculitis disease presented Next Science’s BLASTX data published Patrys’ deoxymabs data presented Patrys (ASX:PAB) jumped 12% this morning after announcing that new data from preclinical studies using PAT-DX1... |
Stockhead | PAB | 8 months ago |
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month
ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr... |
Stockhead | PAB | 9 months ago |
Closing Bell: Buyers ambush benchmark setting new benchmark
Local markets started slow before ripping into an all-time intraday high 10 of 11 sectors higher, benchmark closes 0.50pc up Small Caps led by Motio, Cue Energy and Sierra Rutile Some strong earnings on the last day of February and... |
Stockhead | PAB | 9 months ago |
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs
Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks There were a couple of big news from the world of biotec... |
Stockhead | PAB | 9 months ago |
10 at 11ish: Aurumin to sell iron rights to Mineral Resources
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by... |
Stockhead | PAB | 1 year ago |
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Xi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks China’s President Xi is expected... |
Stockhead | PAB | 1 year ago |
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks Goldman Sachs analysts said they will make no... |
Stockhead | PAB | 1 year ago |
Closing Bell: Local markets end 0.4pc higher led by big banks and a few small biotechs
Benchmark index finishes Friday ahead +0.4% Sectors led by Financials Small caps dominated by Dimerix The ASX200 is up +0.4% at the end of Friday trade, making the week a 1% loss, which we’ll take at this stage. US equities ticked l... |
Stockhead | PAB | 1 year ago |